Alamar Biosciences ALMR Estimates

NASDAQ ALMR
$30.39 -0.30 (-0.98%)
At close: Oct 26, 2026 · 4:00 PM EDT
Analyst Estimates

Alamar Biosciences, Inc. Revenue Estimates

Periods 20
Next Period Q3 26
Consensus 32.01 M

Analysts expect Alamar Biosciences, Inc. to report revenue of 32.01 M for Q3 26, against a range of 29.69 M to 34.33 M. The most recent reported quarter, Q2 26, came in at 29.40 M, a 8.1% beat against the 27.21 M consensus.

Metric Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28Q1 29Q2 29Q3 29Q4 29Q1 30Q2 30Q3 30Q4 30
Reported (Actual) 26.00 M29.40 M--------
High Estimate 29.11 M29.80 M34.33 M36.76 M41.48 M43.98 M45.32 M50.86 M51.42 M61.06 M
Low Estimate 26.23 M24.61 M29.69 M30.80 M34.40 M40.96 M42.60 M43.19 M42.16 M52.19 M
Consensus Estimate 27.67 M27.21 M32.01 M33.78 M37.94 M42.47 M43.96 M47.02 M46.79 M56.62 M
Analyst Estimates

Alamar Biosciences, Inc. Earnings Per Share (EPS) Estimates

Periods 20
Next Period Q3 26
Consensus -0.21

Analysts expect Alamar Biosciences, Inc. to report earnings per share of -0.21 for Q3 26, against a range of -0.23 to -0.19. The most recent reported quarter, Q2 26, came in at -0.22, a 26.7% beat against the -0.30 consensus.

Metric Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28Q1 29Q2 29Q3 29Q4 29Q1 30Q2 30Q3 30Q4 30
Reported (Actual) -1.74-0.22--------
High Estimate -1.53-0.29-0.19-0.17-0.17-0.16-0.09-0.07-0.030.08
Low Estimate -1.73-0.31-0.23-0.21-0.19-0.20-0.11-0.07-0.030.06
Consensus Estimate -1.63-0.30-0.21-0.19-0.18-0.18-0.10-0.07-0.030.07

Alamar Biosciences, Inc. Estimates API

Pull Wall Street consensus for Alamar Biosciences, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/estimates?ticker=ALMR&mode=revenue&api_key=YOUR_API_KEY